Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins

Yijing Li(The University of Texas MD Anderson Cancer Center), Yang Liu(The University of Texas MD Anderson Cancer Center)

Cell Death and Disease

November 2, 2023

10.1038/s41419-023-06233-w

Cited by 11

Related Papers

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

|Journal of Clinical Oncology|2021|82